glp-1 fatty liver disease π¬ Big news for anyone managing β this one's worth knowing about! A study just published this week in one of the world's top medical journals asked a question Animal studies on glucagon-like peptide-1
Description
Clinical data consistently shows that lean mass accounts for approximately 25 to 40 percent of total weight lost during GLP-1 receptor agonist therapy
That said, there are still options to manage your weight
They can assess your suitability based on NICE guidelines and your individual clinical needs, and prescribe approved injectable formulations if appropriate
Others feel strangely flat
GLP-1 This wonder drug has been making waves in the weight loss community and is changing lives forever
If the issue persists, a clinician can review your treatment and provide guidance
